PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic jan.brabek@natur.cuni.cz karel.smetana@lf1.cuni.cz.\', \'BIOCEV, Vestec, Czech Republic.\', \'Department of Cell Biology, Faculty of Sciences, Charles University, Prague, Czech Republic.\', \'BIOCEV, Vestec, Czech Republic jan.brabek@natur.cuni.cz karel.smetana@lf1.cuni.cz.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.21873/invivo.12135
?:doi
?:hasPublicationType
?:journal
  • In vivo (Athens, Greece)
is ?:pmid of
?:pmid
?:pmid
  • 32871847
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.
?:type

Metadata

Anon_0  
expand all